For animal primary conversion, the company must risk-assess potential prohibited substances such as pharmaceuticals, veterinary medicines, heavy metals and pesticides, whether within clause 3.5.1.1 or separately, and include the results in raw material acceptance and testing and in supplier approval and monitoring.
The graph holds this control, the 0 it maps to, and the evidence behind each claim, over MCP and REST.